| Position | Action |
|---|---|
| Price reaches $128-130 with observable technical deterioration (RSI divergence, declining volume, MACD rolling over, or bearish engulfing) | Trim 12-17% of position |
| Price reaches $132-135 with continued technical deterioration | Trim remaining 13-18% of position |
SPCX is a generational infrastructure company undergoing simultaneous buildouts in reusable launch, Starlink-direct-to-mobile, and AI data centers that the market is mispricing as a broken growth story; the technical and fundamental setup offers asymmetric risk/reward with defined downside of ~$10 against upside of $20-26 over 4-8 weeks.
| Indicator | Value | Signal |
|---|---|---|
| Latest Close | $125.33 | bullish |
| 10 EMA | $118.21 | bullish |
| 50 SMA | $144.00 | bearish |
| 200 SMA | $144.00 | bearish |
| MACD Line | -8.51 | bullish |
| MACD Signal Line | -9.35 | bullish |
| MACD Histogram | +0.85 | bullish |
| RSI | 45.77 | neutral |
| RSI Low (2026-07-20) | 28.22 | bullish |
| Bollinger Upper Band | $151.81 | neutral |
| Bollinger Middle Band (20 SMA) |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
SPCX Hold at $125.33: Trim 25-35% at $130-135 on technical deterioration confirmation only
The right expression is Hold with a defined contingency plan. Sell into the supply zone the research manager correctly identified ($130-135), but only after the bounce delivers price to that level with observable technical deterioration (RSI divergence, declining volume, MACD rolling over, or bearish engulfing pattern). Layer a put spread ($110/$90 Sep-Oct) as convex protection against the structural thesis playing out earlier than the bounce-resolution timeline. Second-order risks (capex dependency, lockup supply, valuation) are real but already second-order. The first-order risk is the reflexive bounce into $130-135, which the prior lessons demonstrate is the dominant signal in this regime.
The forward EPS inflection within 12 months signals a profitable company, not a broken one
↩ rebuts: “Bear focus on trailing GAAP loss while ignoring forward earnings curve”
· concedes: Operating cash flow ($1.05B) is positive but not yet sufficient to fully self-fund $18B quarterly capex without supplemental debt/equity; Forward P/E of 138x is elevated even for an inflection story; GAAP net income remains negative driven by depreciation on massive PP&E base and stock compensation; The 50 SMA and 200 SMA at $144 represent $19 of overhead resistance; Musk has a history of over-promising on timing (Starlink delayed multiple times, Starship 'years away' for years); The company remains dependent on capital markets to fund its capex program; Starlink-direct-to-mobile faces regulatory hurdles and incumbent pushback; Post-IPO volatility and lockup overhang are real near-term supply concerns
The market is correctly pricing a structurally, mechanically, and fundamentally fragile company—the bull case has load-bearing cracks the market is already accounting for.
· concedes: $1B revenue beat was delivered; $13.24B deferred revenue is real and represents meaningful future revenue recognition if execution holds; Today's 113.6M volume could include some institutional accumulation (though attribution is uncertain); The technical bounce from $108 is a real 'relief rally' even if not a reversal; Post-IPO names occasionally do recover post-lockup (CAVA example)
→ vs conservative: Wait-for-$130-close-with-volume confirmation is lazy and expensive; $1B revenue beat produced 6% after-hours drop, confirming repricing already in progress—waiting for more bad news to confirm bad news is intellectually incoherent
→ vs neutral: Negative bias without action is the worst of both worlds: takes downside if stock breaks $108 but doesn't capture asymmetric short upside; discomfort is not a position and the market doesn't pay for it
| $125.31 |
| bullish |
| Bollinger Lower Band | $98.81 | neutral |
| ATR | $9.63 | bullish |
| ATR Peak | $16.43 (2026-07-06) | neutral |
| Volume | 113.6M | bullish |
| Prior Day Volume | 70.5M | neutral |
| Intraday High | $126.71 | neutral |
| Intraday Low | $115.72 | neutral |
| 52-Week High | $211.39 (2026-06-16) | neutral |
| Recent Low | $108.37 (2026-07-31) | neutral |
Support: 118.21 · 115.72 · 108.37 · 98.81 | Resistance: 126.71 · 130 · 144 · 151.81
SPCX is experiencing a sharp technical reversal from deeply oversold conditions, with momentum indicators (MACD bullish crossover, RSI recovery from 28.22 to 45.77) signaling a shift in short-term sentiment. The stock closed at $125.33, reclaiming both the 10 EMA ($118.21) and Bollinger midline ($125.31) on elevated volume of 113.6M shares — nearly double the prior day's volume. However, price remains deeply below the 50/200 SMA resistance convergence at $144, and the report recommends HOLD pending confirmation of a break above $130, with aggressive traders permitted to enter with a stop below $115.72 targeting $144 first.
Market Capitalization
$1.651T
52-Week High
$225.64
52-Week Low
$107.01
50-Day / 200-Day Moving Average
$145.41
Book Value per Share
$5.96
Forward P/E
138.79x
Trailing EPS (TTM)
-$0.68
Forward EPS
$0.903
TTM Revenue
$19.30B
TTM Net Income
-$9.36B
TTM EBITDA
$3.95B
Q1 2026 Total Revenue
$4.694B
Q1 2026 Cost of Revenue
$2.388B
Q1 2026 Gross Profit
$2.306B
Q1 2026 Gross Margin
49.1%
Q1 2026 R&D Expense
$3.514B
Q1 2026 SG&A
$746M
Q1 2026 Operating Income
-$1.954B
Q1 2026 Operating Margin
-41.6%
Q1 2026 Net Income
-$4.276B
Q1 2026 Diluted EPS
-$0.41
Q1 2026 Operating Cash Flow
+$1.047B
Q1 2026 Capital Expenditure
-$10.114B
Q1 2026 Free Cash Flow
-$9.067B
Q1 2026 Long-Term Debt Issued
$22.694B
Q1 2026 Common Stock Issued
$8.319B
Q1 2026 End Cash Position
$16.608B
Total Assets
$102.09B
Cash & Short-term Investments
$23.68B
Total Debt
$30.60B
Net Debt
$14.41B
Stockholders' Equity
$41.58B
Retained Earnings
-$41.31B
Deferred Revenue
$13.24B
Current Ratio
1.217x
D/E Ratio (Adjusted)
0.74x
P/B Ratio
21.04x
Profit Margin (TTM)
-45.0%
Net PP&E
$55.06B
Construction in Progress
$14.05B
Strengths
Concerns
SpaceX (SPCX) presents a high-risk, high-reward investment thesis centered on massive technology deployment (Starship, Starlink Gen2, Starshield). The company is investing aggressively with ~$40B annualized capex and 126% YoY R&D growth, resulting in deeply negative FCF (-$9.07B Q1) and GAAP losses (-$4.28B Q1 net loss). However, underlying business health is solid: 15.4% revenue growth, positive operating cash flow (+44% YoY), positive EBITDA ($3.95B TTM), and strong liquidity ($23.68B cash). The valuation is premium (Forward P/E 138.8x, P/B 21x) with an expected earnings inflection signaled by forward EPS of $0.903. The bull case hinges on Starlink sustained profitability, Starship achieving routine operations, and defense contracts scaling; the bear case centers on unsustainable cash burn requiring continuous capital raises with limited margin for execution missteps. Traders should focus on milestone catalysts (Starship cadence, Starlink subscriber growth, defense contract awards) rather than traditional value metrics.